# AbbVie: portfolio, investments and team

> AbbVie is a corporate vc based in United States. 53 investments on record, 4 in the last 12 months, latest Jun 2026. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/abbvie (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# AbbVie

Last cheque observed Jun 2026; 53 cheques on record.

Deploying now Corporate VC

Growth Seed Series A BioTech Biotechnology Computer

Deploying now

**36%** of best year **4** **cheques in 12 months**, 53 on record

Since the last cheque **147** days **00** hrs **00** min **00** sec

Median round **$45M** Rounds led **0 of 53** Sole investor **5 rounds** Mostly in **United States, 81%**

Pitch AbbVie

## AbbVie highlights

- 01 4 cheques in the last 12 months
- 02 Mostly Series A and Venture: 67% of its rounds
- 03 Sole investor in 5 rounds, median $9.7M

## What they do

- **Type:** Corporate VC (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Growth Seed Series A Series B
- **Sectors:** BioTech Biotechnology Computer
- **Based in:** North Chicago, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **53 appearances**

- **2026** 2 rounds
- **Jun** **[Inventiva Pharma](https://millionrounds.com/company/inventiva-pharma)** FR **$120M** With 4 others
- **Apr** **[Endlyz Therapeutics](https://millionrounds.com/company/endlyz-therapeutics)** Seed · US **$17M** With 1 other
- **2025** 11 rounds
- **Dec** **[DISCO Pharmaceuticals](https://millionrounds.com/company/disco-pharmaceuticals)** Seed · DE **$42M** With 1 other
- **Nov** **[Artios Pharma](https://millionrounds.com/company/artios-pharma)** Series D · GB **$115M** With 5 others
- **Oct** **[Zag Bio](https://millionrounds.com/company/zag-bio)** Series A · US · Firms' own news pages **$80M** With 9 others
- **Aug** **[Oisin Biotechnologies](https://millionrounds.com/company/oisin-biotechnologies)** Series A · US **$10M** Sole investor
- **May** **[Syndeio Biosciences](https://millionrounds.com/company/syndeio-biosciences)** Venture · US **$90M** With 2 others
- **Apr** **[ThirtyFiveBio](https://millionrounds.com/company/thirtyfivebio)** Venture · GB **Undisclosed** With 2 others
- **Apr** **[Starday Foods](https://millionrounds.com/company/starday-foods)** Series A · US **$8.0M** With 4 others
- **Feb** **[AmbAgon Therapeutics](https://millionrounds.com/company/ambagon-therapeutics)** Venture · US **$5.0M** With 2 others
- **Jan** **[Soufflé Therapeutics](https://millionrounds.com/company/souffle-therapeutics)** Series A · US **$200M** With 4 others
- **Jan** **[Light Horse Therapeutics](https://millionrounds.com/company/light-horse-therapeutics)** Series A · US **$62M** With 2 others
- **Jan** **[Cephagenix](https://millionrounds.com/company/cephagenix)** Seed · DK **$9.3M** Sole investor
- **2024** 3 rounds
- **Nov** **[Alector](https://millionrounds.com/company/alector)** Debt · US **$50M** With 5 others
- **Jan** **[Effector Therapeutics](https://millionrounds.com/company/effector-therapeutics)** US **$15M** With 2 others
- **Jan** **[Accent Therapeutics](https://millionrounds.com/company/accent-therapeutics)** Series C · US **$75M** With 2 others
- **2023** 5 rounds
- **Jul** **[Caribou Biosciences](https://millionrounds.com/company/caribou-biosciences)** US **$125M** With 4 others
- **Jun** **[Mozart Therapeutics](https://millionrounds.com/company/mozart-therapeutics)** Series A · US **$25M** With 4 others
- **May** **[Morphic Therapeutic](https://millionrounds.com/company/morphic-therapeutic)** US **$276M** With 5 others
- **May** **[Quanta Therapeutics](https://millionrounds.com/company/quanta-therapeutics)** Series D · US **$51M** With 1 other
- **Feb** **[Capsida Biotherapeutics](https://millionrounds.com/company/capsida-biotherapeutics)** Venture · US **Undisclosed** With 1 other
- **2022** 3 rounds
- **Dec** **[Ribon Therapeutics](https://millionrounds.com/company/ribon-therapeutics)** Venture · US **$25M** With 1 other
- **Nov** **[Jnana Therapeutics](https://millionrounds.com/company/jnana-therapeutics)** Series C · US **$107M** With 4 others
- **Sept** **[Carisma Therapeutics](https://millionrounds.com/company/carisma-therapeutics)** Series C · US **$30M** With 3 others
- **2021** 2 rounds
- **Nov** **[Nitrase Therapeutics](https://millionrounds.com/company/nitrase-therapeutics)** Series A · US **$7.0M** With 2 others
- **Jul** **[Stemson Therapeutics](https://millionrounds.com/company/stemson-therapeutics)** Series A · US **$15M** With 1 other
- **2020** 6 rounds
- **Dec** **[Faze Medicines](https://millionrounds.com/company/faze-medicines)** Series A **$81M** With 4 others
- **Nov** **[Caraway Therapeutics](https://millionrounds.com/company/caraway-therapeutics)** Venture **Undisclosed** With 3 others
- **Sept** **[Palleon Pharmaceuticals](https://millionrounds.com/company/palleon-pharmaceuticals)** Series B **$100M** With 2 others
- **Jul** **[Magnolia NeuroSciences](https://millionrounds.com/company/magnolia-neurosciences)** Venture **$18M** With 3 others
- **Jan** **[PACT Pharma](https://millionrounds.com/company/pact-pharma)** Series C **$75M** With 3 others
- **Jan** **[Quench Bio](https://millionrounds.com/company/quench-bio)** Series A **$50M** With 2 others
- **2019** 2 rounds
- **Aug** **[Carisma Therapeutics](https://millionrounds.com/company/carisma-therapeutics)** Series A · US · Technical **$60M** With 1 other
- **Mar** **[Prevail Therapeutics](https://millionrounds.com/company/prevail-therapeutics)** Series B · US · Medcitynews **$50M** With 10 others
- **2018** 8 rounds
- **Dec** **[Quentis Therapeutics](https://millionrounds.com/company/quentis-therapeutics)** Grant **$1.0M** With 4 others
- **Nov** **[Ribometrix](https://millionrounds.com/company/ribometrix)** Series A · US · FinSMEs **$30M** With 10 others
- **Nov** **[Rodeo Therapeutics](https://millionrounds.com/company/rodeo-therapeutics)** Venture **$8.9M** With 3 others
- **Aug** **[ApoGen](https://millionrounds.com/company/apogen)** Series A · US · FinSMEs **$4.0M** With 3 others
- **Aug** **[Magnolia Neuroscience](https://millionrounds.com/company/magnolia-neuroscience)** Series A · US · FinSMEs **$31M** With 10 others
- **Aug** **[Artios](https://millionrounds.com/company/artios)** Series B · GB · FinSMEs **$83M** With 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **13** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Companies it bought

Acquisitions by the firm itself

**Pharmacyclics** **$21B** Mar 2015

**Shire** **$55B** Jul 2014

## The cheque

Growth Seed Series A

Median round joined **$45M** the round, not its cheque Alone, median **$9.7M**

Led 0 of 53 rounds **0%**

- **Sole investor:** 5 rounds
- **Last cheque:** Jun 2026

Rounds by stage said on their site

- Series A said *19*
- Venture *9*
- Series B said *7*
- Series C *4*
- Seed said *3*
- Growth said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Eli Lilly](https://millionrounds.com/fund/eli-lilly) 7
- [Polaris Partners](https://millionrounds.com/fund/polaris-partners) 7
- [Alexandria Venture Investments](https://millionrounds.com/fund/alexandria-venture-investments) 6
- [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 5
- [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 5
- [Sofinnova Partners](https://millionrounds.com/fund/sofinnova-partners) 5

**Pitching AbbVie?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as AbbVie. A count of rooms they were both in, not a relationship either has claimed.

[**Eli Lilly** Corporate VC **7** rounds together](https://millionrounds.com/fund/eli-lilly)[**Polaris Partners** VC firm **7** rounds together](https://millionrounds.com/fund/polaris-partners)[**Alexandria Venture Investments** VC firm **6** rounds together](https://millionrounds.com/fund/alexandria-venture-investments)[**ARCH Venture Partners** VC firm **5** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**RA Capital Management** Private equity **5** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Sofinnova Partners** VC firm **5** rounds together](https://millionrounds.com/fund/sofinnova-partners)[**Versant Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/versant-ventures)[**Alexandria Real Estate Equities** VC firm **4** rounds together](https://millionrounds.com/fund/alexandria)[**SR One** Corporate VC **4** rounds together](https://millionrounds.com/fund/sr-one)[**Google Ventures** Corporate VC **3** rounds together](https://millionrounds.com/fund/gv)[**Mission BioCapital** VC firm **3** rounds together](https://millionrounds.com/fund/mission-biocapital)[**Pfizer** Corporate VC **3** rounds together](https://millionrounds.com/fund/pfizer)

## Recently backed

The latest companies AbbVie put money into.

[**Inventiva Pharma** $120M · Jun 2026](https://millionrounds.com/company/inventiva-pharma)[**Artios Pharma** $115M · Nov 2025](https://millionrounds.com/company/artios-pharma)[**Zag Bio** $80M · Oct 2025](https://millionrounds.com/company/zag-bio)[**Oisin Biotechnologies** $10M · Aug 2025](https://millionrounds.com/company/oisin-biotechnologies)[**Syndeio Biosciences** $90M · May 2025](https://millionrounds.com/company/syndeio-biosciences)[**ThirtyFiveBio** Apr 2025](https://millionrounds.com/company/thirtyfivebio)

## Quick answers about AbbVie

### What does AbbVie invest in?

AbbVie invests most often at Series A and Venture (67% of the rounds on record), in sectors such as BioTech, Biotechnology and Computer.

### How active is AbbVie?

53 investments on record, 4 of them in the last 12 months. The most recent was in Jun 2026.

### What has AbbVie invested in recently?

Its most recent investments on record: Inventiva Pharma (Undisclosed round, Jun 2026), Endlyz Therapeutics (Seed, Apr 2026) and DISCO Pharmaceuticals (Seed, Dec 2025).

### How big are AbbVie's cheques?

The median round it joins is $45M.

### Does AbbVie lead rounds?

Rarely, if at all: none of its 53 investments on record names it as the lead.

### Where does AbbVie invest?

Most of the companies it backs are in the United States (81%) and the United Kingdom (9%).

### Is AbbVie investing now?

Yes: it is actively investing, with 4 investments in the last 12 months.

### Who does AbbVie invest alongside?

Most often Eli Lilly (7 rounds together), Polaris Partners (7 rounds together) and Alexandria Venture Investments (6 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=abbvie) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=abbvie)